N/A N=80 Treatment

T-116_Procera-Bridge Zirconia - A Clinical Study

Partial Edentulism

Bottom Line

View on ClinicalTrials.gov: NCT02186808 ↗

Enrolled (actual)

Serious AEs

3.8%

Results posted

Apr 2016

Primary outcome: Primary: Success Rate of Bridge Procera Bridge Zirconia — 100 percentage of successful implants — p=<0.05

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Procera® Bridge Zirconia (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Nobel Biocare
Primary completion: Apr 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Success Rate of Bridge Procera Bridge Zirconia	95.8	—
SECONDARY Success Rate of Bridge Procera Bridge Zirconia	95.8	—

Summary

The objective of the study is to evaluate the clinical performance of Procera® Bridge Zirconia veneered with NobelRondo Zirconia.

Eligibility Criteria

Inclusion Criteria

Patients planned for treatment with a tooth-supported 3 to 4-unit bridge in any position of the maxilla or the mandible
Indication: same indication as for metal supported bridges
Obtained informed consent from the patient

Exclusion criteria

Currently known alcohol, drug or medication abuse, judged by the investigator, which might influence the follow-up program
Patients where a bridge part connection area of 3 mm of diameter is not possible to obtain (short clinical crowns)
Mobility of the abutment teeth exceeding grade I
Patients with pathologic pocket formation at abutment teeth
Patients with complete dentures in the opposing jaw
Patients with a removable partial denture in the same jaw

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02186808). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.